2-PHENYLBENZO[B]FURANS - RELATIONSHIP BETWEEN STRUCTURE, ESTROGEN-RECEPTOR AFFINITY AND CYTOSTATIC ACTIVITY AGAINST MAMMARY-TUMOR CELLS

被引:0
作者
ERBER, S [1 ]
RINGSHANDL, R [1 ]
VONANGERER, E [1 ]
机构
[1] UNIV REGENSBURG,INST PHARM,UNIV STR 31,W-8400 REGENSBURG,GERMANY
来源
ANTI-CANCER DRUG DESIGN | 1991年 / 6卷 / 05期
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A number of 2-(4-hydroxyphenyl)benzo[b]furans with a hydroxy group in position 5 or 6 and a short alkyl group at C-3 were synthesized from appropriate 1,2-diarylethanones and studied for their estrogen receptor affinity. The relative binding affinities in the 5-hydroxy series were higher than those of 6-hydroxy derivatives by a factor of 10. The trifluoroethyl and the propyl derivatives displayed the best relative binding affinity values (33 (15a) and 20 (12a); 17-beta-estradiol = 100). All benzofurans with high receptor affinity were tested for specific cytostatic activity using hormone-sensitive human MCF-7 mammary tumor cells and hormone-independent MDA-MB 231 cells. 5-Hydroxy derivatives with an ethyl (11a) or a propyl (12a) group completely inhibited the growth of MCF-7 cells at a concentration of 5-mu-M (tamoxifen: 70% inhibition). Since the cytostatic activity in MDA-MB 231 cells was much lower, an anti-tumor effect mainly mediated by the estrogen receptor has to be assumed. In the mouse uterine weight test these compounds gave rise to a partial estrogen antagonism which may account for the inhibitory effect in estrogen-sensitive tumor cells.
引用
收藏
页码:417 / 426
页数:10
相关论文
共 9 条
[1]   EFFECT OF TRIPHENYLACRYLONITRILE DERIVATIVES ON ESTRADIOL-RECEPTOR BINDING AND ON HUMAN-BREAST CANCER CELL-GROWTH [J].
BIGNON, E ;
PONS, M ;
DEPAULET, AC ;
DORE, JC ;
GILBERT, J ;
ABECASSIS, J ;
MIQUEL, JF ;
OJASOO, T ;
RAYNAUD, JP .
JOURNAL OF MEDICINAL CHEMISTRY, 1989, 32 (09) :2092-2103
[2]  
LERNER LJ, 1990, CANCER RES, V50, P4177
[3]   COMPUTERIZED DETERMINATION OF GROWTH KINETIC CURVES AND DOUBLING TIMES FROM CELLS IN MICROCULTURE [J].
REILE, H ;
BIRNBOCK, H ;
BERNHARDT, G ;
SPRUSS, T ;
SCHONENBERGER, H .
ANALYTICAL BIOCHEMISTRY, 1990, 187 (02) :262-267
[4]   ANTITUMOR-ACTIVITY OF ANTIESTROGENIC PHENYLINDOLES ON EXPERIMENTAL PROSTATE TUMORS [J].
SCHNEIDER, MR ;
VONANGERER, E ;
HOHN, W ;
SINOWATZ, F .
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1987, 23 (07) :1005-1015
[5]   1,1,2-TRIPHENYLBUT-1-ENES - RELATIONSHIP BETWEEN STRUCTURE, ESTRADIOL-RECEPTOR AFFINITY, AND MAMMARY-TUMOR INHIBITING PROPERTIES [J].
SCHNEIDER, MR ;
VONANGERER, E ;
SCHONENBERGER, H ;
MICHEL, RT ;
FORTMEYER, HP .
JOURNAL OF MEDICINAL CHEMISTRY, 1982, 25 (09) :1070-1077
[6]   SYNTHESIS AND ESTROGEN-RECEPTOR AFFINITY OF 2,3-DIARYLINDOLES [J].
STROHMEIER, J ;
VONANGERER, E .
ARCHIV DER PHARMAZIE, 1987, 320 (05) :407-417
[7]   2-PHENYLINDOLES - EFFECT OF N-BENZYLATION ON ESTROGEN-RECEPTOR AFFINITY, ESTROGENIC PROPERTIES, AND MAMMARY-TUMOR INHIBITING ACTIVITY [J].
VONANGERER, E ;
STROHMEIER, J .
JOURNAL OF MEDICINAL CHEMISTRY, 1987, 30 (01) :131-136
[8]   2-PHENYLINDOLES - RELATIONSHIP BETWEEN STRUCTURE, ESTROGEN-RECEPTOR AFFINITY, AND MAMMARY-TUMOR INHIBITING ACTIVITY IN THE RAT [J].
VONANGERER, E ;
PREKAJAC, J ;
STROHMEIER, J .
JOURNAL OF MEDICINAL CHEMISTRY, 1984, 27 (11) :1439-1447
[9]  
VONANGERER E, 1989, ANTI-CANCER DRUG DES, V4, P21